UPMC participates in ongoing dialogue with the Embassy of the Republic of Kazakhstan in Washington, DC, the U.S. Embassy in Astana, Kazakhstan, and with the friends and partners of UPMC, both domestically and internationally, who have an active interest the progress of UPMC’s partnership with Nazarbayev University to build the National Research Oncology Center.
The Astana Economic Forum (AEF) is committed to improving and addressing issues of economic development throughout the Eurasian region and the global community. Charles Bogosta, executive vice president of UPMC, president of UPMC International and president of UPMC CancerCenter, is expected to speak on behalf of UPMC, focusing on the economic opportunities of developing more efficient and effective models for delivering cancer care. AEF works with society leaders across fields including politics, business and academics to identify challenges, solutions and actions in an effort to better serve the public.
At the request of Dr. Ken Alibek, Dr. Frank Lieberman, professor of Neurology, Neurosurgery and Medical Oncology, University of Pittsburgh School of Medicine, and director of the Adult Neuro-Oncology program at the UPMC Cancer Center, visited the National Research Center for Oncology and Transplantology and the National Center for Neurosurgery hospitals in Kazakhstan. He toured the facilities and discussed the resource of the Centers as well as the respective roles of the faculty members in multidisciplinary care for patients with neuro-oncologic diagnoses. Dr. Lieberman reviewed the clinical records of 25 neuro-oncology patients treated with a protocol developed by Dr. Alibek for patients with advanced cancer. The patients were brought to the National Research Center for Oncology and Transplantology for examination by Dr. Lieberman.
Dr. Lieberman spent three days reviewing these cases and had the opportunity to meet with Dr. Alibek for comprehensive discussions about program goals at the beginning and end of the visit, in addition to presenting a lecture on current clinical trials in treatment of patients with malignant gliomas. After his visit, Dr. Lieberman reported a clear sense that the program leaders essential to the work of collaborative neuro-oncology trials are committed and eager to begin developing the necessary infrastructure for the future of patient care in Kazakhstan.